Jane Lowe Meisel, MD, is an Associate Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine, with a secondary appointment in the Department of Gynecology and Obstetrics. She joined the Glenn Family Breast Center at Winship Cancer Institute as a practicing physician in 2015. Prior to her arrival, she served as the Chief Fellow in Hematology-Oncology at Memorial Sloan Kettering Cancer Center in New York.

Dr. Meisel is a medical oncologist with a special interest in women's health and in cancers that affect women, including breast, cervical, endometrial, and ovarian cancers. Her goal is to provide compassionate, exceptional, state-of-the-art care to patients fighting these diseases, and to conduct research that improves treatment options for these patients.

Dr. Meisel is a member of the Eastern Cooperative Oncology Group and serves on the Development Therapeutics Committee at NRG Oncology. She also serves as leader of the Professional Development Committee Women in Oncology Work Group and as a member of the Cancer Education Committee at American Society of Clinical Oncology.

A native of Atlanta, Dr. Meisel graduated magna cum laude from Harvard College in 2004 with a degree in the History of Science, and earned her medical degree in 2008 from Harvard Medical School. She completed her residency in internal medicine at Brigham and Women's Hospital in Boston, MA in 2011; during that time, she also conducted research on breast cancer at the Dana-Farber Cancer Institute. She completed her fellowship in medical oncology at Memorial Sloan Kettering Cancer Center in New York, NY, and served as Chief Fellow there from 2013 to 2014.

Dr. Meisel has presented her research on breast cancer and gynecologic malignancies at national meetings and has published her work in peer-reviewed journals. Her research is focused on the development of new therapeutic options for women with gynecologic and breast cancers, and on improving quality of life for these patients. She serves as the principal investigator for many therapeutic trials for patients with breast and gynecologic malignancies at Winship Cancer Institute.